Targeting formyl peptide receptor 1 by anteiso-C13-surfactin for neutrophil-dominant acute respiratory distress syndrome.
Shun-Chin YangYi-Hsuan WangChiu-Ming HoYung-Fong TsaiPing-Jyun SungTony Eight LinTsong-Long HwangPublished in: British journal of pharmacology (2023)
IA-1 serves as the therapeutics for treating ARDS by inhibiting FPR1-mediated neutrophilic injury.